As of Sep 29
| -0.38 / -3.85%|
The 7 analysts offering 12-month price forecasts for Epizyme Inc have a median target of 25.00, with a high estimate of 39.00 and a low estimate of 17.00. The median estimate represents a +163.16% increase from the last price of 9.50.
The current consensus among 8 polled investment analysts is to Buy stock in Epizyme Inc. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.